Prospective comparison of cognitive and mpMR/US fusion biopsy for prostate cancer detection
- 作者: Petov V.S1, Bazarkin A.K1, Morozov A.O1, Taratkin M.S1, Ganzha T.M1, Danilov S.P.1, Chernov Y.N1, Chinenov D.V1, Amosov A.V1, Enikeev D.V1, Krupinov G.E1
-
隶属关系:
- Sechenov University
- 期: 编号 4 (2022)
- 页面: 38-43
- 栏目: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/277104
- DOI: https://doi.org/10.18565/urology.2022.4.38-43
- ID: 277104
如何引用文章
详细
全文:
作者简介
V. Petov
Sechenov University
Email: pettow@maii.ru
M.D., researcher Institute for UroIogy and Reproductive Health
A. Bazarkin
Sechenov University
Email: ak.bazarkin@gmaii.com
Student
A. Morozov
Sechenov University
Email: andrei.o.morozov@gmaii.com
M.D., PhD, senior researcher, Institute for UroIogy and Reproductive HeaIth
M. Taratkin
Sechenov University
Email: marktaratkin@gmaii.com
researcher
T. Ganzha
Sechenov University
Email: timurmed@hotmail.com
M.D.
S. Danilov
Sechenov University
Email: spdaniiov@gmaii.com
M.D.
Y. Chernov
Sechenov University
Email: yarik.chernov@mail.ru
M.D.
D. Chinenov
Sechenov UniversityM.D.
A. Amosov
Sechenov University
Email: amosov-av@yandex.ru
M.D., professor
D. Enikeev
Sechenov University
Email: dvenikeev@gmail.com
M.D., professor
G. Krupinov
Sechenov University
Email: gekrupinov@mail.ru
M.D., professor
参考
- Клинические рекомендации. Рак предстательной железы. 2021; Available from: https://oncology-association.ru/wp-content/uploads/2021/02/rpzh.pdf
- De Santis M., Fanti S., Gillessen S., Grummet J., Henry A., Lam T., et al. Prostate Cancer EAU-EANM-ESTRO-ESUR-SIOG Guidelines on. 2019
- Drost F.-J.H., Osses D.F., Nieboer D., Steyerberg E.W., Bangma C.H., Roobol M.J., et al. Prostate M.R.I., with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019 Apr;4(4), doi: 10.1002/14651858.CD012663.PUB2/
- Kasivisvanathan V., Rannikko A.S., Borghi M., Panebianco V., Mynderse L.A., Vaarala M.H., et al. MRI-Targeted or Standard Biopsy for Prostate -Cancer Diagnosis. N. Engl J. Med [Internet]. 2018 Mar 18 [cited 2022 Jan 8] ;378(19). Available from: https://pubmed.ncbi.nlm.nih.gov/29552975/, doi: 10.1056/NEJMOA1801993.
- Rouviere O., Puech P., Renard-Penna.R., Claudon M., Roy C., Mege-Lechevallier F., et al. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2019;20(1), doi: 10.1016/S1470-2045(18)30569-2.
- Zhang K., Zhang Z., Liu M., Zhu G., Roobol M.J. Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naive biopsy patients. Transl Androl Urol [Internet]. 2020 Apr 1 [cited 2022 Jan 31];9(2):243. Available from: /pmc/articles/PMC7214969/. doi: 10.21037/tau.2020.02.20.
- Elkhoury F.F., Felker E.R., Kwan L., Sisk A.E., Delfin M., Natarajan S., et al. Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive: The Prospective Assessment of Image Registration in the Diagnosis of Prostate Cancer (PAIREDCAP) Study. JAMA Surg [Internet]. 2019 Sep 1 [cited 2022 Jan 31];154(9):811. Available from: /pmc/articles/PMC6563598/. doi: 10.1001/JAMASURG.2019.1734.
- Wegelin O., Exterkate L., van derLeest M., Kummer J.A., Vreuls W., de Bruin P.C., et al. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies. Eur Urol. 2019;75(4):582- 590. doi: 10.1016/j.eururo.2018.11.040.
- Panebianco V., Barchetti F., Manenti G., Aversa T., Catalano C., Simonetti G. MR imaging-guided prostate biopsy: technical features and preliminary results. Radiol Med [Internet]. 2015 Jun 22 [cited 2022 Jan 31];120(6):571- 578. Available from: https://pubmed.ncbi.nlm.nih.gov/25578784/. doi: 10.1007/S11547-014-0490-0.
- Yaxley A.J., Yaxley J.W., Thangasamy I.A., Ballard E., Pokorny M.R. Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesions. BJU Int. 2017 Nov 1;120:43-50, doi: 10.1111/BJU.13971.
- Mottet N., van den Bergh R.C.N., Briers E., Van den Broeck T., Cumberbatch M.G., De Santis M., et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Vol. 79, European Urology. Eur Urol; 2021. 243-262. doi: 10.1016/j.eururo.2020.09.042.
- Wegelin O., Exterkate L., van der Leest M., Kelder J.C., Bosch J.L.H.R., Barentsz J.O., et al. Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial. Eur Urol Oncol. 2019 Nov;2(6):617-624. doi: 10.1016/j.euo.2019.08.007.
- Turkbey B., Rosenkrantz A.B., Haider M.A., Padhani A.R., Villeirs G. Macura K.J., et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol [Internet]. 2019 Sep 1 [cited 2022 Jan 8];76(3):340-51. Available from: https://pubmed.ncbi.nlm.nih.gov/30898406/. Doi: 10.1016/J. EURURO.2019.02.033.
- Moore C.M., Kasivisvanathan V., Eggener S., Emberton M., FOtterer J.J., Gill I.S.,. et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: Recommendations from an international working group. Eur Urol. 2013. doi: 10.1016/j.eururo.2013.03.030.
- Stabile A., Dell’Oglio P., Gandaglia G., Fossati N., Brembilla G., Cristel G., et al. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Eur Urol Oncol [Internet]. 2018 Jun 1 [cited 2022 Feb 21];1(2):120-128. Available from: https://pubmed.ncbi.nlm.nih.gov/31100235/. Doi: 10.1016/J. EUO.2018.02.002.
- Kaufmann S., Russo G.I.,. Bamberg F., Lowe L., Morgia G., Nikolaou K., et al. Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, roboticor in-bore MRI target biopsy. World J. Urol. 2018;36(5):761-768. doi: 10.1016/J.EUO.2018.02.002.
- Oberlin D.T., Casalino D.D., Miller F.H., Matulewicz R.S., Perry K.T., Nadler R.B., et al. Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate. Urology [Internet]. 2016 Jun 1 [cited 2022 Feb 18];92:75-79. Available from: https://pubmed.ncbi.nlm.nih.gov/26966043/. doi: 10.1016/J.UROLOGY.2016.02.041.
- Watts K.L., Frechette L., Muller B., Ilinksy D., Kovac E., Sankin A., et al. Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer. Urol Oncol [Internet]. 2020 Sep 1 [cited 2022 Feb 18];38(9):734.e19-734. e25. Available from: https://pubmed.ncbi.nlm.nih.gov/32321689/. doi: 10.1016/J.UROLONC.2020.03.02.
- Valerio M., McCartan N., Freeman A., Punwani S., Emberton M., Ahmed H.U. Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer. Urol Oncol [Internet]. 2015 Oct 1 [cited 2022 Feb 20];33(10):424.e9-424.e16. Available from: https://pubmed.ncbi.nlm. nih.gov/26195330/. doi: 10.1016/J.UROLONC.2015.06.012.
- Oderda M., Faletti R., Battisti G., Dalmasso E., Falcone M., Marra G., et al. Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study. Urol Int. 2016 Aug 1;97(2):230-237. doi: 10.1159/000445524.
- Delongchamps N.B., Peyromaure M., Schull A., Beuvon.F., Bouazza N., Flam T., et al. Prebiopsy magnetic resonance imaging and prostate cancer detection: Comparison of random and targeted biopsies. J. Urol. 2013 Feb;189(2):493-499, doi: 10.1016/J.JURO.2012.08.195.
- Monda S.M., Vetter J.M., Andriole G.L., Fowler K.J., Shetty A.S., Weese J.R., et al. Cognitive Versus Software Fusion for MRI-targeted Biopsy: Experience Before and After Implementation of Fusion. Urology [Internet]. 2018 Sep 1 [cited 2022 Feb 20];119:115-20. Available from: https://pubmed.ncbi.nlm.nih.gov/29940232/. doi: 10.1016/J.UROLOGY.2018.06.011.
- Klingebiel M., Arsov C., Ullrich T., Quentin M., Al-Monajjed R., Mally D., et al. Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy. Eur J. Radiol [Internet]. 2021 Apr 1 [cited 2022 Feb 20];137. Available from: https://pubmed.ncbi.nlm.nih.gov/33592552/. Doi: 10.1016/J. EJRAD.2021.109587.
- Xu G., Xiang L., Wu J., Shao H., Liu H., Ding S., et al. The accuracy of prostate lesion localization in cognitive fusion. Clin Hemorheol Microcirc. 2020;74(3):223-229. doi: 10.3233/CH-180423.
- Pepe P., Garufi A., Priolo G.D., Pennisi M. Multiparametric MRI/TRUS Fusion Prostate Biopsy: Advantages of a Transperineal Approach. Anticancer Res [Internet]. 2017 Jun 1 [cited 2022 Feb 1] ;37(6):3291- 3294. Available from: https://pubmed.ncbi.nlm.nih.gov/28551679/. doi: 10.21873/ANTICANRES.11695.
- Loy L.M., Lim G.H., Leow J.J., Lee C.H., Tan T.W., Tan C.H. A systematic review and meta-analysis of magnetic resonance imaging and ultrasound guided fusion biopsy of prostate for cancer detection-Comparing transrectal with transperineal approaches. Urol Oncol [Internet]. 2020 Aug 1 [cited 2022 Feb 1];38(8):650-660. Available from: https://pubmed.ncbi.nlm.nih.gov/32505458/. doi: 10.1016/J.UROLONC.2020.04.005.